Global Blood Glucose Monitoring System Market – Growth Factor, Analysis and Forecast 2024| VynZ Research

Diabetes mellitus is the group of chronic endocrine disorder due to insufficient level of insulin. Prolonged hyperglycemia (high blood sugar) can lead to severe complications including cardiovascular disease, kidney failure, diabetic retinopathy or nephropathy, and ulcers. Blood glucose monitoring systems are used for the testing of blood glucose level in the body. The global blood glucose monitoring system market is growing at significant rate due to increasing prevalence of diabetes. The market is expected to grow at the faster rate for continuous blood glucose monitoring products in the coming years due to increasing adoption of minimally invasive procedure.

Get Free Report Sample at:

Blood Glucose Monitoring System

On the basis of testing site, the blood glucose monitoring system market is segment into fingertip testing and alternate site testing. Fingertip testing is the most common technique used for measurement of blood glucose level. Fingertip testing segment has the larger share and is also expected to grow at the faster rate due to high reliability and accuracy of fingertip testing.

Geographically, North America is the largest blood glucose monitoring system market as the region has favorable reimbursement policies, increasing awareness program and rising FDA approvals. Increasing prevalence of diabetes has fueled the growth of the North American blood glucose monitoring system market. For instance, according to Centers for Disease Control and Prevention (CDC), in 2015, approximately 23.1 million people in the U.S. had diabetes.

Explore Full Report Description at:

Asia-Pacific is observed to witness the fastest growth in demand for blood glucose monitoring products. Increasing prevalence of diabetes, increasing awareness of diabetes, increasing healthcare expenditure, and large population base are creating a positive impact on the blood glucose monitoring systems market growth in the region.

Key players in the blood glucose monitoring system market are investing in the development of innovative and advance products, which is strengthening their position in the market. In September 2016, Abbott gained FDA approval for the FreeStyle Libre Pro continuous glucose monitoring (CGM) device, a professional-use device to provide better diabetes management to diabetes patient. In addition, in August 2016, Roche launched the Accu-Chek Guide, the next-generation blood glucose monitoring system. Abbott Laboratories, B. Braun Melsungen, F. Hoffmann-La Roche, Ypsomed, Lifescan, Medtronic, Ascensia Diabetes Care, Dexcom, Nipro and Sanofi are the key players offering blood glucose monitoring products.

Kundan Kumar
Manager: Client Care
Connect With us:Linkedin | Twitter |Google | Facebook

Author: VynZ Research

VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.